Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

Michael O'Riordan

March 13, 2025

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

Michael O'Riordan

December 03, 2015

News Daily News

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Michael O'Riordan

December 03, 2015

News Daily News

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Michael O'Riordan

December 03, 2015

Advertisement

Take Heed of Sex Differences in Peripheral Vascular Disease: AHA

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

BP Reduction With Renal Denervation Still Evident a Decade On

Reduction in BP Drives Treatment Preference for Hypertensive Patients

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content